{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:06:04Z","timestamp":1793462764762,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50 CA186781"],"award-info":[{"award-number":["P50 CA186781"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.mayocp.2018.08.006","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T02:06:51Z","timestamp":1550023611000},"source":"Crossref","is-referenced-by-count":48,"title":["A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry\u2013Verified Typing"],"prefix":"10.1016","author":[{"given":"Eli","family":"Muchtar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morie A.","family":"Gertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Kyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha Q.","family":"Lacy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dingli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis K.","family":"Buadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne R.","family":"Hayman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Lisa","family":"Hwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amie","family":"Fonder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Gonsalves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taxiarchis V.","family":"Kourelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahma","family":"Warsame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Lust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald S.","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Zeldenrust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Vincent","family":"Rajkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaji K.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Dispenzieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mayocp.2018.08.006_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/asheducation-2017.1.1","article-title":"AL amyloidosis: from molecular mechanisms to targeted therapies","volume":"2017","author":"Merlini","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1016\/j.mayocp.2018.08.006_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/13506129.2016.1257986","article-title":"Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines","volume":"23","author":"Sipe","year":"2016","journal-title":"Amyloid"},{"issue":"9","key":"10.1016\/j.mayocp.2018.08.006_bib3","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1182\/blood-2005-10-4148","article-title":"Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteins","volume":"107","author":"Comenzo","year":"2006","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.mayocp.2018.08.006_bib4","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1056\/NEJMoa013354","article-title":"Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis","volume":"346","author":"Lachmann","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.mayocp.2018.08.006_bib5","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCULATIONAHA.115.018852","article-title":"Heart failure resulting from age-related cardiac amyloid disease associated with wild-type transthyretin: a prospective, observational cohort study","volume":"133","author":"Connors","year":"2016","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.mayocp.2018.08.006_bib6","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.mayocp.2017.09.016","article-title":"Prevalence of monoclonal gammopathy in wild-type transthyretin amyloidosis","volume":"92","author":"Geller","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"24","key":"10.1016\/j.mayocp.2018.08.006_bib7","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.mayocp.2018.08.006_bib8","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/eurheartj\/ehx043","article-title":"Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths","volume":"38","author":"Gonzalez-Lopez","year":"2017","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.mayocp.2018.08.006_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.carpath.2012.09.001","article-title":"Relationship between monoclonal gammopathy and cardiac amyloid type","volume":"22","author":"Maleszewski","year":"2013","journal-title":"Cardiovasc Pathol"},{"issue":"14","key":"10.1016\/j.mayocp.2018.08.006_bib10","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1182\/blood-2014-11-609883","article-title":"A\u00a0practical approach to the diagnosis of systemic amyloidoses","volume":"125","author":"Fernandez de Larrea","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.mayocp.2018.08.006_bib11","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1182\/blood-2011-06-358507","article-title":"Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients","volume":"119","author":"Schonland","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.mayocp.2018.08.006_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/MNH.0b013e32835fe37c","article-title":"Mass spectrometry based proteomics in the diagnosis of kidney disease","volume":"22","author":"Sethi","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"24","key":"10.1016\/j.mayocp.2018.08.006_bib13","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1182\/blood-2009-07-230722","article-title":"Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens","volume":"114","author":"Vrana","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.mayocp.2018.08.006_bib14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000443200","article-title":"Immunoglobulin light-chain amyloidosis: from basics to new developments in diagnosis, prognosis and therapy","volume":"135","author":"Muchtar","year":"2016","journal-title":"Acta Haematol"},{"issue":"2","key":"10.1016\/j.mayocp.2018.08.006_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/qjmed\/91.2.141","article-title":"The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement","volume":"91","author":"Dubrey","year":"1998","journal-title":"QJM"},{"issue":"12","key":"10.1016\/j.mayocp.2018.08.006_bib16","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0025-6196(12)65706-1","article-title":"Primary systemic amyloidosis: a diagnostic primer","volume":"64","author":"Gertz","year":"1989","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.mayocp.2018.08.006_bib17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood.V77.2.257.257","article-title":"Response rates and survival in primary systemic amyloidosis","volume":"77","author":"Gertz","year":"1991","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.mayocp.2018.08.006_bib18","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0002-9343(90)90179-H","article-title":"Beta 2-microglobulin predicts survival in primary systemic amyloidosis","volume":"89","author":"Gertz","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.mayocp.2018.08.006_bib19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archinte.1961.03620030032004","article-title":"\u201cPrimary\u201d systemic amyloidosis and myeloma: discussion of relationship and review of 81 cases","volume":"107","author":"Kyle","year":"1961","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.mayocp.2018.08.006_bib20","first-page":"45","article-title":"Primary systemic amyloidosis: clinical and laboratory features in 474 cases","volume":"32","author":"Kyle","year":"1995","journal-title":"Semin Hematol"},{"issue":"3","key":"10.1016\/j.mayocp.2018.08.006_bib21","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood.V93.3.1062","article-title":"Long-term survival (10 years or more) in 30 patients with primary amyloidosis","volume":"93","author":"Kyle","year":"1999","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.mayocp.2018.08.006_bib22","first-page":"665","article-title":"Amyloidosis (AL): clinical and laboratory features in 229 cases","volume":"58","author":"Kyle","year":"1983","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.mayocp.2018.08.006_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/ajcp\/96.1.95","article-title":"The predictive value of bone marrow morphologic characteristics and immunostaining in primary (AL) amyloidosis","volume":"96","author":"Wu","year":"1991","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.mayocp.2018.08.006_bib24","series-title":"Manual of Clinical Laboratory Immunology","first-page":"71","article-title":"Immunochemical characterization of immunoglobulins","author":"Kyle","year":"2002"},{"issue":"4","key":"10.1016\/j.mayocp.2018.08.006_bib25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajh.20381","article-title":"Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004","volume":"79","author":"Gertz","year":"2005","journal-title":"Am J Hematol"},{"issue":"18","key":"10.1016\/j.mayocp.2018.08.006_bib26","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1200\/JCO.2004.03.029","article-title":"Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis","volume":"22","author":"Dispenzieri","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.mayocp.2018.08.006_bib27","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements","volume":"30","author":"Kumar","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"36","key":"10.1016\/j.mayocp.2018.08.006_bib28","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1200\/JCO.2011.37.7614","article-title":"New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes","volume":"30","author":"Palladini","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.mayocp.2018.08.006_bib29","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1182\/blood.V52.4.818.bloodjournal524818","article-title":"Primary systemic amyloidosis: comparison of melphalan and prednisone versus placebo","volume":"52","author":"Kyle","year":"1978","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.mayocp.2018.08.006_bib30","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/0002-9343(85)90521-2","article-title":"Primary systemic amyloidosis: comparison of melphalan\/prednisone versus colchicine","volume":"79","author":"Kyle","year":"1985","journal-title":"Am J Med"},{"issue":"15","key":"10.1016\/j.mayocp.2018.08.006_bib31","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1182\/blood-2016-11-751628","article-title":"Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death","volume":"129","author":"Muchtar","year":"2017","journal-title":"Blood"},{"issue":"9371","key":"10.1016\/j.mayocp.2018.08.006_bib32","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S0140-6736(03)13396-X","article-title":"Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins","volume":"361","author":"Dispenzieri","year":"2003","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.mayocp.2018.08.006_bib33","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1161\/01.CIR.0000068314.02595.B2","article-title":"Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis","volume":"107","author":"Palladini","year":"2003","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.mayocp.2018.08.006_bib34","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1161\/01.CIR.0000068313.67758.4F","article-title":"Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis","volume":"107","author":"Koyama","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.mayocp.2018.08.006_bib35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcmg.2009.09.023","article-title":"Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis","volume":"3","author":"Syed","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.mayocp.2018.08.006_bib36","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/13506120500107055","article-title":"Multicentre versus single centre approach to rare diseases: the model of systemic light chain amyloidosis","volume":"12","author":"Palladini","year":"2005","journal-title":"Amyloid"},{"issue":"10","key":"10.1016\/j.mayocp.2018.08.006_bib37","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2013-07-517938","article-title":"Leukocyte cell-derived chemotaxin 2 (LECT2)-associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States","volume":"123","author":"Mereuta","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.mayocp.2018.08.006_bib38","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1182\/blood-2017-02-767475","article-title":"AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosis","volume":"130","author":"Dittrich","year":"2017","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.mayocp.2018.08.006_bib39","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1182\/blood-2010-06-290668","article-title":"Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features","volume":"116","author":"Kumar","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.mayocp.2018.08.006_bib40","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1182\/blood-2017-02-767467","article-title":"Patients with light-chain amyloidosis and low free light-chain burden have distinct clinical features and outcome","volume":"130","author":"Milani","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.mayocp.2018.08.006_bib41","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/leu.2017.286","article-title":"Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains","volume":"32","author":"Sidana","year":"2018","journal-title":"Leukemia"},{"issue":"34","key":"10.1016\/j.mayocp.2018.08.006_bib42","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1200\/JCO.2013.50.8499","article-title":"Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis","volume":"31","author":"Kourelis","year":"2013","journal-title":"J\u00a0Clin Oncol"}],"updated-by":[{"DOI":"10.1016\/j.mayocp.2019.05.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000}}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619618306104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619618306104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T15:38:35Z","timestamp":1573918715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619618306104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":42,"alternative-id":["S0025619618306104"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2018.08.006","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}